1. SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for
Clotrimazole and Betamethasone Dipropionate Cream USP, 1% 0.05%, the therapeutic equivalent of Lotrisone Cream USP, 1% 0.05% of Merck,
SharpandDohmeCorporation.AccordingtoIMSHealth salesdataforthe12monthperiodendingSeptember2015,theLotrisoneCreamUSP,1%
0.05% market1 achieved annual sales of approximately $82.4 million. Glenmark’s current portfolio consists of 103 products authorized for
distribution in the US marketplace and 63 ANDA’s pending approval with the USFDA. In addition to these internal filings, Glenmark continues to
identifyandexploreexternaldevelopmentpartnershipstosupplementandacceleratethegrowthofitsexistingpipelineandportfolio.
Technical Outlook : On daily, chart is forming Rounding Bottom formation which is bullish reversal pattern. Moreover, stock has formed
InvertedHammer candlesticknear thebottomwithaboveaveragevolume,whichisbullishreversalsignandindicatingfortrendreversal.A
momentumindicatorRSIreadingisat39.78 levelwithpositive crossoverandrecentlycomeoutfromitsoversoldzone,whichpointoutfor
positivebreathinthestock.Sofortradingperspective,onecouldBuyintherangeof889-895fortheTargetof913withtheSLof880.
GLENMARK
MARUTI
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
18th Dec 2015
Buy in the range of 4655-4670 for the Target of 4765 with the SL of 4608
Buy in the range of 889-895 for the Target of 913 with the SL of 880
Maruti SuzukiIndia Limited (MSIL) today said the company's minority shareholders have given a go-ahead toa proposal to develop manufacturing
facilities in Gujarat through a 100 per cent subsidiary owned by parent Suzuki Motor Corporation (SMC). Maruti Suzuki has got 89.75% votes in
favouroftheproposalforarelatedpartytransactionwithSuzukiMotorGujarat,withover50%shareholdersabstainedfromvoting.Effectively,the
ordinaryresolutionhasbeenpassedwithrequisitemajority.
Technical Outlook :On daily chart, stock has formed Hammer shapedof candlestick withthe support of its 21 Day Moving Average
which is double confirmation for further upside movement inthe counter.Moreover, stock has beentradingwithitsstrongsupport
of its 50 Day Moving Average which is placed at 4530 level, whichshows that medium term trend is up. Amomentum indicator RSI
reading is at 58.18 level with positive crossover, which point out for positive breath in the counter. So for trading perspective, one
couldBuyintherangeof4655-4670fortheTargetof4765withtheSLof4608.
U.S. stocks tumbled nearly 1%, as a Fed-inspired rally stemming from its historic rate hike a session earlier was dented by the
continual downturn in crude oil prices, amid festering concerns related to the supply-demand imbalance on energy markets
worldwide. U.S. crude future prices tumbled below $35 a barrel on Thursday, falling near seven-year lows from the start of the
week.
Despite a strong session on Thursday, the SGX Nifty is indicating a weak opening for the market. Sensex yesterday rallied over 300
points to move closer to the 26,000 mark. Nifty, as well, soared past the 7,800 level. SGX Nifty was trading at 7,809 level, down
about 50 points at the time of writing the copy. On the domestic front, the Reserve Bank of India (RBI) released norms to calculate
baseratebyusingmarginalcostoffunds.Asianmarketsopenedlowerbyhalftoaroundonepercentduetoprofitbooking.
2. SEBI Certified – Research Analyst www.choiceindia.com
Bulk Deal
Corporate Action / Result Calendar
SEBI Certified – Research Analyst www.choiceindia.com
Morning Tea
Corporate Action:
Man Industries (India) Limited; Annual General Meeting/ Dividend - Rs 1.50/- Per Share
(Book Closure Dates Revised)
Andhra Cements Limited; Annual General Meeting
Nova Electro Magnetics Limited; Annual General Meeting
Nova Steel India Limited; Annual General Meeting
Result Calendar:
18th Dec 2015
Security in Ban
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Sr. No. Deal Date Script Code Security Name Client Name Deal Type Quantity Price
1 17/12/2015 533896 FERVENTSYN SAMIR VALLABHJI GOSAR . B 618558 22.58
2 17/12/2015 533896 FERVENTSYN VISHWAMURTE TRAD INVEST PE LTD S 310000 22.60
3 17/12/2015 533157 SYNCOM VISHWAMURTE TRAD INVEST PE LTD S 258000 9.44
4 17/12/2015 533157 SYNCOM VISHWAMURTE TRAD INVEST PE LTD B 258000 9.24
5 17/12/2015 533157 SYNCOM AVATAR INDIA OPPORTUNITIES FUND S 250000 9.25
6 17/12/2015 533758 APLAPOLLO R.B.A. FINANCE& INVESTMENT CO. B 235000 752.50
7 17/12/2015 533758 APLAPOLLO SANJAY GUPTA HUF S 210000 752.58
8 17/12/2015 533758 APLAPOLLO SANJAY GUPTA S 196450 769.49
9 17/12/2015 533758 APLAPOLLO INTEGRATED MASTER SECURITIES PRIVATE LIM S 196450 752.35
10 17/12/2015 533758 APLAPOLLO INTEGRATED MASTER SECURITIES PRIVATE LIM B 196450 769.51
IBREALEST, IDBI, JINDALSTEL, JISLJALEQS, JPASSOCIATE & UNITECH
3. SEBI Certified – Research Analyst www.choiceindia.com
Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
SEBI Certified – Research Analyst www.choiceindia.com
Research Team
Mr. Sumeet Bagadia Associate Director
Kunal Parmar Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Kapil Shah Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
18th Dec 2015
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website